dc.creator | Silva, Laís Peres | |
dc.creator | Santos, Ivanilson Pimenta | |
dc.creator | Silva, Dahara Keyse Carvalho | |
dc.creator | Reis, Bruna Padilha Zurita Claro dos | |
dc.creator | Meira, Cássio Santana | |
dc.creator | Castro, Marcos Venícius Batista de Souza | |
dc.creator | Santos Filho, José Maurício dos | |
dc.creator | Araujo Neto, João Honorato de | |
dc.creator | Ellena, Javier Alcides | |
dc.creator | Silveira, Rafael Gomes da | |
dc.creator | Soares, Milena Botelho Pereira | |
dc.date | 2023-02-09T19:43:50Z | |
dc.date | 2023-02-09T19:43:50Z | |
dc.date | 2022 | |
dc.date.accessioned | 2023-09-26T21:03:11Z | |
dc.date.available | 2023-09-26T21:03:11Z | |
dc.identifier | SILVA, Laís Peres et al. Molecular hybridization strategy on the design, synthesis, and structural characterization of ferrocene-n-acyl hydrazones as immunomodulatory agents. Molecules, v. 27, p. 1-22, 2022. | |
dc.identifier | 1420-3049 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/56995 | |
dc.identifier | 10.3390/molecules27238343 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8868373 | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).
Programa de Apoio a Núcleos de Excelência (Pronex). | |
dc.description | Immunomodulatory agents are widely used for the treatment of immune-mediated diseases, but the range of side effects of the available drugs makes necessary the search for new immunomodulatory drugs. Here, we investigated the immunomodulatory activity of new ferrocenyl-N-acyl hydrazones derivatives (SintMed(141–156). The evaluated N-acyl hydrazones did not show cytotoxicity at the tested concentrations, presenting CC50 values greater than 50 µM. In addition, all ferrocenyl-N-acyl hydrazones modulated nitrite production in immortalized macrophages, showing inhibition values between 14.4% and 74.2%. By presenting a better activity profile, the ferrocenyl-N-acyl hydrazones SintMed149 and SintMed150 also had their cytotoxicity and anti-inflammatory effect evaluated in cultures of peritoneal macrophages. The molecules were not cytotoxic at any of the concentrations tested in peritoneal macrophages and were able to significantly reduce (p < 0.05) the production of nitrite, TNF-α, and IL-1β. Interestingly, both molecules significantly reduced the production of IL-2 and IFN-γ in cultured splenocytes activated with concanavalin A. Moreover, SintMed150 did not show signs of acute toxicity in animals treated with 50 or 100 mg/kg. Finally, we observed that ferrocenyl-N-acyl hydrazone SintMed150 at 100 mg/kg reduced the migration of neutrophils (44.6%) in an acute peritonitis model and increased animal survival by 20% in an LPS-induced endotoxic shock model. These findings suggest that such compounds have therapeutic potential to be used to treat diseases of inflammatory origin. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.publisher | MDPI | |
dc.rights | open access | |
dc.subject | Immunomodulation | |
dc.subject | Imunomodulação | |
dc.subject | Choque endotóxico | |
dc.subject | Peritonite aguda | |
dc.subject | N-acil hidrazonas | |
dc.subject | Ferroceno | |
dc.subject | Immunomodulation | |
dc.subject | Endotoxic shock | |
dc.subject | Acute peritonitis | |
dc.subject | N-acyl hydrazones | |
dc.subject | ferrocene | |
dc.title | Molecular hybridization strategy on the design, synthesis, and structural characterization of ferrocene-n-acyl hydrazones as immunomodulatory agents | |
dc.type | Article | |